158 related articles for article (PubMed ID: 34680451)
1. Chemical Modification of Cysteine with 3-Arylpropriolonitrile Improves the In Vivo Stability of Albumin-Conjugated Urate Oxidase Therapeutic Protein.
Yang B; Kwon I
Biomedicines; 2021 Sep; 9(10):. PubMed ID: 34680451
[TBL] [Abstract][Full Text] [Related]
2. Thermostable and Long-Circulating Albumin-Conjugated
Yang B; Kwon I
Pharmaceutics; 2021 Aug; 13(8):. PubMed ID: 34452259
[TBL] [Abstract][Full Text] [Related]
3. Multivalent Albumin-Neonatal Fc Receptor Interactions Mediate a Prominent Extension of the Serum Half-Life of a Therapeutic Protein.
Yang B; Kwon I
Mol Pharm; 2021 Jun; 18(6):2397-2405. PubMed ID: 33983743
[TBL] [Abstract][Full Text] [Related]
4. Enhanced therapeutic potential of antibody fragment via IEDDA-mediated site-specific albumin conjugation.
Go EB; Lee JH; Cho JH; Kwon NH; Choi JI; Kwon I
J Biol Eng; 2024 Apr; 18(1):23. PubMed ID: 38576037
[TBL] [Abstract][Full Text] [Related]
5. Pyrrolobenzodiazepine Antibody-Drug Conjugates Designed for Stable Thiol Conjugation.
Christie RJ; Tiberghien AC; Du Q; Bezabeh B; Fleming R; Shannon A; Mao S; Breen S; Zhang J; Zhong H; Harper J; Wu H; Howard PW; Gao C
Antibodies (Basel); 2017 Nov; 6(4):. PubMed ID: 31548535
[TBL] [Abstract][Full Text] [Related]
6. Effect of C-terminus Conjugation via Different Conjugation Chemistries on In Vivo Activity of Albumin-Conjugated Recombinant GLP-1.
Park J; Bak M; Min K; Kim HW; Cho JH; Tae G; Kwon I
Pharmaceutics; 2021 Feb; 13(2):. PubMed ID: 33672039
[TBL] [Abstract][Full Text] [Related]
7. Site-specific albumination of a therapeutic protein with multi-subunit to prolong activity in vivo.
Lim SI; Hahn YS; Kwon I
J Control Release; 2015 Jun; 207():93-100. PubMed ID: 25862515
[TBL] [Abstract][Full Text] [Related]
8. AlbuCatcher for Long-Acting Therapeutics.
Rho JH; Lee JH; Kwon I
ACS Omega; 2024 May; 9(21):22990-23000. PubMed ID: 38826564
[TBL] [Abstract][Full Text] [Related]
9. Comparative studies of the serum half-life extension of a protein via site-specific conjugation to a species-matched or -mismatched albumin.
Yang B; Kim JC; Seong J; Tae G; Kwon I
Biomater Sci; 2018 Jul; 6(8):2092-2100. PubMed ID: 29881837
[TBL] [Abstract][Full Text] [Related]
10. Improved anticancer delivery of paclitaxel by albumin surface modification of PLGA nanoparticles.
Esfandyari-Manesh M; Mostafavi SH; Majidi RF; Koopaei MN; Ravari NS; Amini M; Darvishi B; Ostad SN; Atyabi F; Dinarvand R
Daru; 2015 Apr; 23(1):28. PubMed ID: 25903677
[TBL] [Abstract][Full Text] [Related]
11. Structures of Arthrobacter globiformis urate oxidase-ligand complexes.
Juan EC; Hoque MM; Shimizu S; Hossain MT; Yamamoto T; Imamura S; Suzuki K; Tsunoda M; Amano H; Sekiguchi T; Takénaka A
Acta Crystallogr D Biol Crystallogr; 2008 Aug; D64(Pt 8):815-22. PubMed ID: 18645230
[TBL] [Abstract][Full Text] [Related]
12. Site-Specific Albumination as an Alternative to PEGylation for the Enhanced Serum Half-Life in Vivo.
Yang B; Lim SI; Kim JC; Tae G; Kwon I
Biomacromolecules; 2016 May; 17(5):1811-7. PubMed ID: 27050863
[TBL] [Abstract][Full Text] [Related]
13. Human serum albumin hydropersulfide is a potent reactive oxygen species scavenger in oxidative stress conditions such as chronic kidney disease.
Shibata A; Ishima Y; Ikeda M; Sato H; Imafuku T; Chuang VTG; Ouchi Y; Abe T; Watanabe H; Ishida T; Otagiri M; Maruyama T
Biochem Biophys Res Commun; 2016 Oct; 479(3):578-583. PubMed ID: 27666483
[TBL] [Abstract][Full Text] [Related]
14. Generation of therapeutic protein variants with the human serum albumin binding capacity via site-specific fatty acid conjugation.
Cho J; Lim SI; Yang BS; Hahn YS; Kwon I
Sci Rep; 2017 Dec; 7(1):18041. PubMed ID: 29269881
[TBL] [Abstract][Full Text] [Related]
15. Intramolecular distance in the conjugate of urate oxidase and fatty acid governs FcRn binding and serum half-life in vivo.
Cho J; Park J; Kim S; Kim JC; Tae G; Jin MS; Kwon I
J Control Release; 2020 May; 321():49-58. PubMed ID: 32006589
[TBL] [Abstract][Full Text] [Related]
16. Site-selective labeling of a lysine residue in human serum albumin.
Asano S; Patterson JT; Gaj T; Barbas CF
Angew Chem Int Ed Engl; 2014 Oct; 53(44):11783-6. PubMed ID: 25196737
[TBL] [Abstract][Full Text] [Related]
17. Recombinant Peptide Production Platform Coupled with Site-Specific Albumin Conjugation Enables a Convenient Production of Long-Acting Therapeutic Peptide.
Bak M; Park J; Min K; Cho J; Seong J; Hahn YS; Tae G; Kwon I
Pharmaceutics; 2020 Apr; 12(4):. PubMed ID: 32316169
[TBL] [Abstract][Full Text] [Related]
18. Selective irreversible chemical tagging of cysteine with 3-arylpropiolonitriles.
Koniev O; Leriche G; Nothisen M; Remy JS; Strub JM; Schaeffer-Reiss C; Van Dorsselaer A; Baati R; Wagner A
Bioconjug Chem; 2014 Feb; 25(2):202-6. PubMed ID: 24410136
[TBL] [Abstract][Full Text] [Related]
19. Long-term stabilization of maleimide-thiol conjugates.
Fontaine SD; Reid R; Robinson L; Ashley GW; Santi DV
Bioconjug Chem; 2015 Jan; 26(1):145-52. PubMed ID: 25494821
[TBL] [Abstract][Full Text] [Related]
20. A head-to-head comparison of conjugation methods for VHHs: Random maleimide-thiol coupling versus controlled click chemistry.
van Moorsel MVA; Urbanus RT; Verhoef S; Koekman CA; Vink M; Vermonden T; Maas C; Pasterkamp G; Schiffelers RM
Int J Pharm X; 2019 Dec; 1():100020. PubMed ID: 31517285
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
